Return to Trial Database

HCRN-LUN96-1

A Phase II Study of Paclitaxel (3-Hour Infusion and Bolus Doxorubicin in Recurrent or Refractory Small Cell Lung Cancer

Status

Study Completed

Cancer Type(s)

Study Contact

Publications

Phase II Study of Doxorubicin and Paclitaxel as Second-Line Chemotherapy of Small-Cell Lung Cancer

Trial Locations

All sites in which the trial HCRN-LUN96-1 being conducted in.

No data was found